Stephen Hanff, MD
Orthopaedic Surgery · Trinity, FLNPI 1437249752
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Coastal Medical Technologies LLC accounts for 67.0% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $190, more than ten times the $12 reported in 2020. That places this record below the midpoint for orthopaedic surgery clinicians in FL, where the typical reported total is $5,564.
Across 11 payments — averaging $33.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coastal Medical Technologies LLC$248
- Johnson & Johnson$36
- Curonix LLC$21
- Amgen$18
- Avanos Medical$17
- Kerecis Limited$17
- plus $13 from 1 others
What the payments were for
- Food & beverage$371100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coastal Medical Technologies LLC | 4 | $248 |
| Johnson & Johnson | 2 | $36 |
| Curonix LLC | 1 | $21 |
| Amgen | 1 | $18 |
| Avanos Medical | 1 | $17 |
| Kerecis Limited | 1 | $17 |
| MVP Orthopedics Inc | 1 | $13 |
How this compares
$371 in reported general payments places this provider in the 15th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 103 | $4,331 |
| Ondansetron OdtOndansetron | 116 | $2,249 |
| Enoxaparin Sodium | 27 | $2,140 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 116 | $1,563 |
| Cephalexin | 14 | $1,038 |
| Methylprednisolone | 68 | $437 |
| Doxycycline Hyclate | 19 | $380 |
| Meloxicam | 91 | $322 |
| Tramadol Hcl | 82 | $294 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 46 | $215 |
| Clindamycin Hcl | 12 | $115 |
| Amoxicillin | 37 | $69 |
| Ibuprofen | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Trinity
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
- Bryan SpringerJacksonville$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.